30 September 2020
Dr Colin Dunkley, Consultant Paediatrician and Clinical Lead for Epilepsy12 tells us about the recent report on the clinical and organisational aspects of epilepsies care for children and young people in England and Wales.
24 July 2020
We respond to the government's announcement of this year's flu vaccination programme, which includes Year 7 for the first time.
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
3 June 2020
We're seeking nominations for people who have made major contributions to paediatrics and child health for two awards: the James Spence Medal, our highest honour; and RCPCH Honorary Fellowship. Nominations are open until 13 August.
1 May 2020
Leading paediatricians in the UK have set out a working definition of an inflammatory syndrome affecting a very small number of children and which may be associated with COVID-19.
30 April 2020
Dame Mary Marsh, Chair of the Board of Trustees welcomes Professor Sir Terence Stephenson to the Board.
24 April 2020
Russell's weekly blog to members looks at how we protect and plan delivery of crucial paediatric services - including immunisations and for vulnerable children - in the context of an extended pandemic.
7 April 2020
Dr Susan Broster has been appointed as our Global Officer, working closely with the staff team and many clinical volunteers to deliver our global child health programmes. Sue replaces Dr Bhanu Williams, who now joins our Board of Trustees.
4 March 2020
The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.